Heide Ford
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homeodomain Proteins | 28 | 2023 | 468 | 7.860 |
Why?
| Protein Tyrosine Phosphatases | 16 | 2024 | 145 | 4.410 |
Why?
| Breast Neoplasms | 19 | 2020 | 1965 | 3.130 |
Why?
| Gene Expression Regulation, Neoplastic | 20 | 2023 | 1167 | 2.630 |
Why?
| Epithelial-Mesenchymal Transition | 9 | 2020 | 176 | 2.490 |
Why?
| Nuclear Proteins | 12 | 2023 | 597 | 2.270 |
Why?
| Intracellular Signaling Peptides and Proteins | 12 | 2023 | 404 | 2.220 |
Why?
| Neoplasm Metastasis | 13 | 2020 | 544 | 1.800 |
Why?
| Vascular Endothelial Growth Factor C | 3 | 2020 | 16 | 1.710 |
Why?
| Neoplastic Stem Cells | 7 | 2021 | 336 | 1.630 |
Why?
| Cell Line, Tumor | 27 | 2023 | 2851 | 1.620 |
Why?
| Transforming Growth Factor beta | 5 | 2012 | 462 | 1.600 |
Why?
| Neoplasms | 13 | 2020 | 2179 | 1.560 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 5 | 2017 | 56 | 1.440 |
Why?
| Cell Transformation, Neoplastic | 5 | 2015 | 317 | 1.410 |
Why?
| Sarcoma, Ewing | 2 | 2023 | 65 | 1.270 |
Why?
| Muscle Development | 2 | 2022 | 102 | 1.260 |
Why?
| MicroRNAs | 4 | 2015 | 637 | 1.240 |
Why?
| Drug Resistance, Neoplasm | 8 | 2017 | 671 | 1.210 |
Why?
| DNA-Binding Proteins | 5 | 2018 | 1346 | 1.200 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 164 | 1.110 |
Why?
| Zebrafish Proteins | 2 | 2022 | 252 | 1.090 |
Why?
| Transcription Factors | 7 | 2022 | 1570 | 1.060 |
Why?
| Mammary Glands, Human | 4 | 2010 | 61 | 1.040 |
Why?
| Up-Regulation | 7 | 2018 | 872 | 0.930 |
Why?
| Cerebellar Neoplasms | 1 | 2023 | 135 | 0.840 |
Why?
| Medulloblastoma | 1 | 2023 | 177 | 0.820 |
Why?
| Rhabdomyosarcoma | 1 | 2022 | 57 | 0.800 |
Why?
| Neuropilin-2 | 1 | 2020 | 3 | 0.790 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 34 | 0.780 |
Why?
| Mammary Neoplasms, Experimental | 5 | 2012 | 63 | 0.770 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 181 | 0.760 |
Why?
| Animals | 39 | 2022 | 33381 | 0.740 |
Why?
| Cell Transdifferentiation | 2 | 2010 | 32 | 0.740 |
Why?
| Cadherins | 2 | 2014 | 186 | 0.720 |
Why?
| Mice, SCID | 8 | 2019 | 333 | 0.700 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 65 | 0.680 |
Why?
| Signal Transduction | 12 | 2020 | 4709 | 0.670 |
Why?
| Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 16 | 0.670 |
Why?
| RNA-Binding Protein EWS | 2 | 2023 | 16 | 0.670 |
Why?
| Epithelial Cells | 5 | 2012 | 963 | 0.660 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.660 |
Why?
| Neoplasm Proteins | 3 | 2018 | 401 | 0.650 |
Why?
| Protein Phosphatase 2 | 1 | 2018 | 35 | 0.640 |
Why?
| Transcriptional Activation | 2 | 2018 | 348 | 0.630 |
Why?
| Mice | 24 | 2022 | 15520 | 0.630 |
Why?
| Zinc Finger Protein GLI1 | 1 | 2017 | 21 | 0.610 |
Why?
| Mice, Inbred NOD | 6 | 2019 | 574 | 0.610 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 115 | 0.600 |
Why?
| Anion Transport Proteins | 1 | 2017 | 12 | 0.590 |
Why?
| Paracrine Communication | 1 | 2017 | 57 | 0.590 |
Why?
| B7-H1 Antigen | 1 | 2018 | 144 | 0.580 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 56 | 0.570 |
Why?
| Cell Proliferation | 11 | 2020 | 2275 | 0.570 |
Why?
| Down-Regulation | 2 | 2015 | 627 | 0.560 |
Why?
| Ribosomal Proteins | 1 | 2015 | 68 | 0.540 |
Why?
| Humans | 54 | 2023 | 118974 | 0.530 |
Why?
| Twist-Related Protein 1 | 1 | 2015 | 10 | 0.520 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 455 | 0.520 |
Why?
| Cell Cycle | 4 | 2013 | 550 | 0.520 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 124 | 0.520 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 551 | 0.510 |
Why?
| Mesoderm | 3 | 2009 | 141 | 0.500 |
Why?
| Epithelium | 3 | 2009 | 305 | 0.490 |
Why?
| Neoplasm Transplantation | 6 | 2014 | 245 | 0.480 |
Why?
| Branchio-Oto-Renal Syndrome | 2 | 2013 | 5 | 0.470 |
Why?
| Transcription, Genetic | 3 | 2014 | 1323 | 0.460 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 900 | 0.460 |
Why?
| Molecular Targeted Therapy | 2 | 2015 | 356 | 0.450 |
Why?
| Lung Neoplasms | 3 | 2019 | 2220 | 0.450 |
Why?
| Superoxide Dismutase | 1 | 2014 | 339 | 0.440 |
Why?
| Female | 26 | 2021 | 61565 | 0.430 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 814 | 0.430 |
Why?
| Lymphangiogenesis | 1 | 2012 | 23 | 0.430 |
Why?
| Cell Differentiation | 7 | 2022 | 1753 | 0.420 |
Why?
| Genes, Tumor Suppressor | 1 | 2012 | 77 | 0.420 |
Why?
| Protein Binding | 7 | 2020 | 1975 | 0.410 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 160 | 0.410 |
Why?
| Antineoplastic Agents | 3 | 2020 | 1974 | 0.390 |
Why?
| Mice, Nude | 7 | 2017 | 663 | 0.390 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 53 | 0.380 |
Why?
| Genes, Homeobox | 3 | 2022 | 51 | 0.370 |
Why?
| Bone Neoplasms | 1 | 2012 | 199 | 0.360 |
Why?
| Cyclin A | 3 | 2009 | 15 | 0.350 |
Why?
| Embryonic Development | 1 | 2010 | 118 | 0.350 |
Why?
| Mice, Inbred BALB C | 4 | 2019 | 1206 | 0.350 |
Why?
| Cell Movement | 5 | 2020 | 896 | 0.320 |
Why?
| Genomic Instability | 1 | 2008 | 38 | 0.320 |
Why?
| Gene Regulatory Networks | 2 | 2023 | 239 | 0.310 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1390 | 0.300 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 740 | 0.290 |
Why?
| Ovarian Neoplasms | 2 | 2012 | 420 | 0.280 |
Why?
| Prognosis | 5 | 2019 | 3443 | 0.280 |
Why?
| Tyrosine | 2 | 2024 | 233 | 0.280 |
Why?
| Heterografts | 3 | 2017 | 130 | 0.280 |
Why?
| Retina | 1 | 2008 | 278 | 0.260 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 311 | 0.260 |
Why?
| Gene Amplification | 1 | 2005 | 97 | 0.260 |
Why?
| Zebrafish | 2 | 2022 | 434 | 0.250 |
Why?
| Rosaniline Dyes | 1 | 2024 | 10 | 0.240 |
Why?
| Protein Stability | 2 | 2018 | 164 | 0.240 |
Why?
| Integrins | 1 | 2023 | 82 | 0.220 |
Why?
| Models, Biological | 4 | 2017 | 1715 | 0.210 |
Why?
| Myogenin | 1 | 2022 | 13 | 0.210 |
Why?
| MyoD Protein | 1 | 2022 | 28 | 0.210 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 17 | 0.210 |
Why?
| MCF-7 Cells | 2 | 2020 | 111 | 0.210 |
Why?
| Disease Progression | 3 | 2015 | 2490 | 0.210 |
Why?
| Cell Survival | 2 | 2017 | 1047 | 0.200 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 462 | 0.200 |
Why?
| Transplantation, Heterologous | 3 | 2012 | 194 | 0.200 |
Why?
| Small Molecule Libraries | 2 | 2019 | 80 | 0.190 |
Why?
| Cell Dedifferentiation | 2 | 2010 | 30 | 0.190 |
Why?
| BRCA1 Protein | 1 | 2020 | 57 | 0.180 |
Why?
| Apoptosis | 3 | 2019 | 2484 | 0.180 |
Why?
| Enzyme Inhibitors | 4 | 2021 | 827 | 0.180 |
Why?
| Hedgehog Proteins | 1 | 2020 | 175 | 0.180 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 11 | 0.170 |
Why?
| Glioblastoma | 1 | 2021 | 262 | 0.170 |
Why?
| Gene Expression Profiling | 3 | 2012 | 1597 | 0.170 |
Why?
| Cyclin A1 | 3 | 2009 | 4 | 0.170 |
Why?
| Antigens, CD | 2 | 2014 | 460 | 0.170 |
Why?
| Mutation | 1 | 2009 | 3457 | 0.160 |
Why?
| Tumor Cells, Cultured | 2 | 2019 | 874 | 0.160 |
Why?
| HEK293 Cells | 2 | 2018 | 625 | 0.160 |
Why?
| Cell Growth Processes | 2 | 2008 | 54 | 0.160 |
Why?
| RNA, Small Interfering | 2 | 2017 | 564 | 0.160 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 842 | 0.150 |
Why?
| Veratrum Alkaloids | 1 | 2017 | 18 | 0.150 |
Why?
| Maxilla | 1 | 2017 | 29 | 0.150 |
Why?
| Proteolysis | 2 | 2017 | 146 | 0.150 |
Why?
| Basigin | 1 | 2017 | 27 | 0.150 |
Why?
| Promoter Regions, Genetic | 3 | 2010 | 1158 | 0.140 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 451 | 0.140 |
Why?
| Cellular Reprogramming | 1 | 2017 | 85 | 0.140 |
Why?
| Clone Cells | 1 | 2016 | 248 | 0.140 |
Why?
| Protein Structure, Tertiary | 2 | 2009 | 823 | 0.140 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 137 | 0.140 |
Why?
| Multigene Family | 2 | 2008 | 200 | 0.140 |
Why?
| Immunohistochemistry | 2 | 2018 | 1691 | 0.140 |
Why?
| Endothelin-1 | 1 | 2017 | 168 | 0.130 |
Why?
| Tumor Burden | 2 | 2017 | 274 | 0.130 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.130 |
Why?
| Trans-Activators | 2 | 2010 | 373 | 0.130 |
Why?
| Cell Nucleus | 2 | 2009 | 580 | 0.130 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 116 | 0.130 |
Why?
| Claudins | 1 | 2014 | 24 | 0.130 |
Why?
| Mass Spectrometry | 1 | 2018 | 681 | 0.120 |
Why?
| Survival Rate | 1 | 2019 | 1720 | 0.120 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2015 | 84 | 0.120 |
Why?
| Genes, MHC Class I | 2 | 2005 | 33 | 0.120 |
Why?
| Pyrimidines | 1 | 2017 | 382 | 0.120 |
Why?
| Child | 2 | 2023 | 19129 | 0.120 |
Why?
| Tumor Microenvironment | 1 | 2017 | 454 | 0.120 |
Why?
| Gene Expression | 3 | 2009 | 1489 | 0.120 |
Why?
| Biomedical Research | 1 | 2020 | 612 | 0.120 |
Why?
| Transfection | 3 | 2017 | 888 | 0.120 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2445 | 0.120 |
Why?
| Aldehyde Dehydrogenase | 1 | 2014 | 134 | 0.120 |
Why?
| Pyridines | 1 | 2017 | 440 | 0.120 |
Why?
| G1 Phase | 1 | 2013 | 68 | 0.120 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2013 | 37 | 0.120 |
Why?
| Phosphorylation | 1 | 2018 | 1633 | 0.120 |
Why?
| Brain Neoplasms | 1 | 2021 | 1022 | 0.110 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2018 | 702 | 0.110 |
Why?
| Autophagy | 1 | 2016 | 315 | 0.110 |
Why?
| Disease-Free Survival | 1 | 2014 | 649 | 0.110 |
Why?
| Cluster Analysis | 2 | 2012 | 481 | 0.110 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1059 | 0.110 |
Why?
| Antibodies, Neoplasm | 1 | 2012 | 30 | 0.110 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2017 | 139 | 0.110 |
Why?
| Etoposide | 1 | 2012 | 149 | 0.110 |
Why?
| Reactive Oxygen Species | 1 | 2014 | 576 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 770 | 0.100 |
Why?
| Energy Metabolism | 1 | 2017 | 767 | 0.100 |
Why?
| Repressor Proteins | 1 | 2014 | 377 | 0.100 |
Why?
| DNA Damage | 2 | 2017 | 357 | 0.100 |
Why?
| Amino Acid Sequence | 4 | 2014 | 2071 | 0.100 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 176 | 0.100 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 44 | 0.100 |
Why?
| Cell Death | 2 | 2021 | 339 | 0.100 |
Why?
| Lymphatic Metastasis | 1 | 2012 | 307 | 0.100 |
Why?
| Doxorubicin | 1 | 2012 | 302 | 0.100 |
Why?
| Antioxidants | 1 | 2014 | 564 | 0.100 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 539 | 0.090 |
Why?
| Antigens, Differentiation | 1 | 2010 | 79 | 0.090 |
Why?
| Metaplasia | 1 | 2009 | 57 | 0.090 |
Why?
| Pancreatic Neoplasms | 1 | 2017 | 734 | 0.090 |
Why?
| Lymphoma | 1 | 2011 | 180 | 0.090 |
Why?
| Follow-Up Studies | 1 | 2019 | 4596 | 0.090 |
Why?
| Smad3 Protein | 1 | 2009 | 47 | 0.090 |
Why?
| Salivary Proteins and Peptides | 1 | 2009 | 10 | 0.090 |
Why?
| Submandibular Gland | 1 | 2009 | 16 | 0.090 |
Why?
| Mutant Proteins | 1 | 2009 | 100 | 0.090 |
Why?
| Lactation | 1 | 2010 | 160 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2009 | 276 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2009 | 338 | 0.080 |
Why?
| Eye Neoplasms | 1 | 2008 | 15 | 0.080 |
Why?
| Oxidative Stress | 1 | 2014 | 1178 | 0.080 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 139 | 0.080 |
Why?
| Protein Transport | 1 | 2009 | 412 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 982 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 969 | 0.080 |
Why?
| Allosteric Regulation | 2 | 2019 | 85 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2021 | 522 | 0.070 |
Why?
| Ubiquitin | 1 | 2006 | 66 | 0.070 |
Why?
| Amino Acid Motifs | 1 | 2006 | 200 | 0.070 |
Why?
| Blotting, Western | 2 | 2011 | 1194 | 0.070 |
Why?
| Crystallography, X-Ray | 2 | 2019 | 422 | 0.070 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2005 | 17 | 0.070 |
Why?
| Ovary | 1 | 2007 | 205 | 0.070 |
Why?
| Antigens, CD1 | 1 | 2005 | 60 | 0.070 |
Why?
| Chickens | 1 | 2005 | 185 | 0.060 |
Why?
| Precipitin Tests | 1 | 2004 | 93 | 0.060 |
Why?
| Models, Molecular | 3 | 2019 | 1435 | 0.060 |
Why?
| Phylogeny | 2 | 2005 | 816 | 0.060 |
Why?
| Cell Line | 2 | 2014 | 2707 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2009 | 2025 | 0.060 |
Why?
| RNA, Messenger | 2 | 2012 | 2657 | 0.060 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 35 | 0.060 |
Why?
| Cyclin D1 | 1 | 2003 | 61 | 0.060 |
Why?
| Dogfish | 1 | 2003 | 4 | 0.060 |
Why?
| Fibroblasts | 1 | 2008 | 842 | 0.060 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 4908 | 0.060 |
Why?
| DNA, Complementary | 1 | 2003 | 268 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2012 | 3730 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1945 | 0.050 |
Why?
| DNA | 1 | 2009 | 1388 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 776 | 0.050 |
Why?
| Neovascularization, Pathologic | 1 | 2004 | 287 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2005 | 454 | 0.050 |
Why?
| Developmental Biology | 1 | 2020 | 18 | 0.050 |
Why?
| Neural Stem Cells | 1 | 2021 | 120 | 0.050 |
Why?
| Cell Plasticity | 1 | 2020 | 24 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 483 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 2014 | 2871 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 2 | 2014 | 372 | 0.040 |
Why?
| Terminology as Topic | 1 | 2020 | 211 | 0.040 |
Why?
| Peptides | 1 | 2024 | 879 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 212 | 0.040 |
Why?
| Treatment Outcome | 1 | 2012 | 9342 | 0.040 |
Why?
| Pregnancy | 1 | 2010 | 5691 | 0.040 |
Why?
| Consensus | 1 | 2020 | 534 | 0.040 |
Why?
| Sp7 Transcription Factor | 1 | 2017 | 8 | 0.040 |
Why?
| Zygoma | 1 | 2017 | 11 | 0.040 |
Why?
| Serrate-Jagged Proteins | 1 | 2017 | 30 | 0.040 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.040 |
Why?
| Branchial Region | 1 | 2017 | 34 | 0.040 |
Why?
| Receptor, Endothelin A | 1 | 2017 | 60 | 0.040 |
Why?
| Craniofacial Abnormalities | 1 | 2017 | 58 | 0.040 |
Why?
| Autophagy-Related Proteins | 1 | 2016 | 46 | 0.040 |
Why?
| Diphtheria Toxin | 1 | 2016 | 63 | 0.040 |
Why?
| Receptors, Notch | 1 | 2017 | 85 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2017 | 220 | 0.040 |
Why?
| Body Patterning | 1 | 2017 | 131 | 0.040 |
Why?
| Integrases | 1 | 2017 | 123 | 0.040 |
Why?
| Epidermal Growth Factor | 1 | 2016 | 173 | 0.030 |
Why?
| Neural Crest | 1 | 2017 | 117 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 198 | 0.030 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 403 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 290 | 0.030 |
Why?
| Cell Adhesion | 1 | 2017 | 443 | 0.030 |
Why?
| Calcium Signaling | 1 | 2017 | 219 | 0.030 |
Why?
| RNA Interference | 1 | 2017 | 460 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2016 | 395 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 76 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 59 | 0.030 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 101 | 0.030 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 25 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 150 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 653 | 0.030 |
Why?
| Amino Acids | 1 | 2017 | 465 | 0.030 |
Why?
| Adult | 1 | 2015 | 31512 | 0.030 |
Why?
| DNA Primers | 2 | 2005 | 533 | 0.030 |
Why?
| Phenylhydrazines | 1 | 2012 | 3 | 0.030 |
Why?
| Protein Phosphatase 2C | 1 | 2012 | 14 | 0.030 |
Why?
| Miniaturization | 1 | 2012 | 24 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6412 | 0.030 |
Why?
| Fluoresceins | 1 | 2012 | 47 | 0.030 |
Why?
| Enzyme Assays | 1 | 2012 | 23 | 0.030 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 45 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 240 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2012 | 67 | 0.030 |
Why?
| Spleen | 2 | 2005 | 510 | 0.030 |
Why?
| Antibody Specificity | 1 | 2012 | 184 | 0.030 |
Why?
| Spectrometry, Fluorescence | 1 | 2012 | 173 | 0.030 |
Why?
| DNA Fragmentation | 1 | 2011 | 48 | 0.020 |
Why?
| Sequence Analysis, DNA | 2 | 2005 | 755 | 0.020 |
Why?
| Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| Mutation, Missense | 1 | 2013 | 300 | 0.020 |
Why?
| High-Throughput Screening Assays | 1 | 2012 | 122 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 339 | 0.020 |
Why?
| Male | 2 | 2021 | 57801 | 0.020 |
Why?
| Brain | 1 | 2021 | 2490 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1624 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 334 | 0.020 |
Why?
| Organ Size | 1 | 2009 | 460 | 0.020 |
Why?
| Bursa of Fabricius | 1 | 2005 | 2 | 0.020 |
Why?
| Blotting, Southern | 1 | 2005 | 67 | 0.020 |
Why?
| Sequence Homology | 1 | 2005 | 40 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 194 | 0.020 |
Why?
| Conserved Sequence | 1 | 2005 | 219 | 0.020 |
Why?
| Sequence Alignment | 1 | 2005 | 336 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2005 | 510 | 0.020 |
Why?
| Mice, Knockout | 1 | 2009 | 2680 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 253 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2003 | 546 | 0.010 |
Why?
| Base Sequence | 1 | 2005 | 2159 | 0.010 |
Why?
| Biological Evolution | 1 | 2003 | 443 | 0.010 |
Why?
| Genetic Variation | 1 | 2003 | 926 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2005 | 2062 | 0.010 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|